Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Jianpi Tongqiao decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for the treatment of allergic rhinitis in children, particularly those exhibiting the Lung and Spleen Qi Deficiency pattern. Developed and studied by The Affiliated Hospital of Qingdao University, the decoction is designed to alleviate nasal symptoms by modulating the immune response. Its mechanism involves balancing the Th1/Th2 cytokine ratio, specifically by reducing levels of interleukin-4 (IL-4) and increasing interferon-gamma (IFN-γ) in the serum. Research into the decoction also employs metabonomics to identify metabolic biomarkers and clarify the systemic effects of the treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yiqi jianpi tongqiao decoction.